LRP4 and congenital myasthenic syndrome: Mutations in Lrp4 that reduce Agrin–Lrp4–MuSK signaling, without perturbing Wnt signaling, cause a neuromuscular disease, termed congenital myasthenia (Ohkawara et al., 2014).